Reaction

Pancreaticoduodenectomy reporting signals

Last recalculated 2026-09-14T18:28:35.993900+00:00 · 640 reports · 4 co-occurring drugs

As of the last recalculation, Pancreaticoduodenectomy appears in 640 FAERS reports alongside 4 co-occurring drug terms. The strongest observed disproportionality signal is PANCRELIPASE (PRR 657.9).

Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
DrugCo-reportsPRRROR
Pancrelipase352657.9664.0
Sitagliptin13778.478.5
Sitagliptin And Metformin Hydrochloride4572.973.1
Exenatide3019.419.4

Related reactions

Data source: openFDA FAERS. See the OpenPV methodology and limitations.